Biotalys NV (DE:86C) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Biotalys NV has secured EUR 15 million in funding through a private placement, issuing new shares to investors including Ackermans & van Haaren NV and ASR Vermogensbeheer NV. The funds will advance their AGROBODY™ technology platform and biocontrol product pipeline, including their biofungicide EVOCA™ awaiting regulatory approval. The investment is intended to support further R&D, regulatory processes, and the company’s strategic growth in sustainable crop protection.
For further insights into DE:86C stock, check out TipRanks’ Stock Analysis page.